Digital health company PneumoWave has announced the closing of a £7.5m Series A financing.
The round will enable clinical validation and regulatory submission of the company’s biosensor technology platform for remote wireless diagnosing and monitoring potentially fatal respiratory changes in high-risk patient groups.
PneumoWave co-founder and CEO, Dr Bruce Henderson, said:
“We are delighted to close this round and thank both our existing investors and the Scottish National Investment Bank for their support.
“Working with leading international centres, we will now be able to accelerate our clinical validation leading to a planned regulatory submission in early 2024.
“We believe our platform will provide an invaluable tool for increasing the effectiveness of opioid use disorder treatment programmes as well as respiratory disorders in general.”
PneumoWave is a development stage digital health company, with locations in Scotland and the US.
Its proprietary digital technology provides real-time physiological data and patient-centric digital biomarkers and focuses on preventing deaths and reducing hospital admissions from respiratory causes.
Paul Callaghan, Director Innovation, at investor the Scottish National Investment Bank, said:
“The Bank’s support for PneumoWave will help their aim of being able to remotely diagnose and monitor high-risk patients with respiratory conditions. This commercial investment has the potential to positively impact significant public health issues in this country and beyond.”
PneumoWave’s technology is being developed as part of an international research programme in collaboration with the University of Dundee, King’s College London, University of Glasgow and NRCH and Department of Health in Victoria, Australia.
Mark Bamforth of investor Thairm Bio, said:
“This is a great opportunity to support the PneumoWave team to bring their platform to the US to help deliver more effective treatment programmes for both opioid use and general respiratory disorders.”
Digital twins set to advance stroke care
Can AI help keep the human experience in social care?
mRNA discovery paves the way to safer vaccines
Eye scans provide crucial insights into kidney health
Key tips for accelerating the health security compliance journey
Nordic Consulting strengthens team in Ireland
Healthcare innovators and leaders honoured at Imprivata HealthCon user group and awards ceremony
Wearable communication system may reduce digital health divide
Molecule trains the immune system to prevent cancer
Diabetes patients urged to use fitness games with caution
- Medtech4 weeks ago
UK student team wins world Heart Hackathon competition
- Interviews1 week ago
Photodisinfectant: can light curb the antimicrobial resistance crisis?
- News3 weeks ago
Where next for the shared care record (or the connected care record)?
- News1 week ago
Listen: Longevity, Eastern wisdom and Western science